ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$13.46

Market cap

$6.64B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.5

Enterprise value

$12.06B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
The debt is down by 2.3% since the previous quarter
The quick ratio has grown by 39% YoY but it has contracted by 8% from the previous quarter
ELAN's equity is down by 15% YoY
The company's EPS fell by 8% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
492.97M
Market cap
$6.64B
Enterprise value
$12.06B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.07
Price to sales (P/S)
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.73
Earnings
Revenue
$4.42B
EBIT
-$918M
EBITDA
-$224M
Free cash flow
$131M
Per share
EPS
-$2.5
Free cash flow per share
$0.27
Book value per share
$12.63
Revenue per share
$8.97
TBVPS
$9.7
Balance sheet
Total assets
$14.36B
Total liabilities
$8.14B
Debt
$5.77B
Equity
$6.22B
Working capital
$2.17B
Liquidity
Debt to equity
0.93
Current ratio
2.75
Quick ratio
1.1
Net debt/EBITDA
-24.21
Margins
EBITDA margin
-5.1%
Gross margin
56.3%
Net margin
-27.9%
Operating margin
-20.8%
Efficiency
Return on assets
-8.2%
Return on equity
-18.1%
Return on invested capital
-10%
Return on capital employed
-7%
Return on sales
-20.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
4.1%
1 week
-1.32%
1 month
-14.92%
1 year
34.87%
YTD
-9.66%
QTD
-17.32%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.42B
Gross profit
$2.49B
Operating income
-$918M
Net income
-$1.23B
Gross margin
56.3%
Net margin
-27.9%
Elanco Animal Health's net income has decreased by 8% from the previous quarter
The net margin is down by 6% since the previous quarter
Elanco Animal Health's operating income has decreased by 3.7% from the previous quarter
The company's operating margin fell by 2.5% QoQ

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
ELAN P/E details
P/E
N/A
P/B
1.07
P/S
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.73
The company's EPS fell by 8% QoQ
The price to book (P/B) is 34% higher than the last 4 quarters average of 0.8 but 24% lower than the 5-year quarterly average of 1.4
ELAN's equity is down by 15% YoY
ELAN's P/S is 44% below its 5-year quarterly average of 2.7 but 15% above its last 4 quarters average of 1.3

Efficiency

How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROE has decreased by 12% from the previous quarter
The company's return on assets fell by 9% QoQ
Elanco Animal Health's ROIC has decreased by 2% from the previous quarter
The company's return on sales fell by 2.5% QoQ

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 76% higher than its total liabilities
Elanco Animal Health's current ratio has increased by 42% YoY but it has decreased by 2.5% from the previous quarter
The quick ratio has grown by 39% YoY but it has contracted by 8% from the previous quarter
The debt is 7% smaller than the equity
The debt to equity has increased by 16% year-on-year but it has declined by 3.1% since the previous quarter
ELAN's equity is down by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.